An Assessment of Emerging Molecular Farming Activities Based on Patent Analysis (2002-2006)
The products of Plant Molecular Farming are recombinant proteins or their metabolic products. In this study, patent data
was employed to assess industrial trend in the research and innovation process of Plant Molecular Farming within national
and international context. The US Patent and Trade Organization (USPTO), the European Patent Office (EPO) issued
a total of 585 patents covering Plant Molecular Farming from 2002 through 2006. By nationality, US inventors predominated
as recipients of PMF patents, followed by Germany, Denmark, and Japan. The PMF patents were catagorized
in five major areas of research namely pharmaceutical and nutraceuticals with 170 patents (31%) and plant expression
tools and methods for alternative production systems with 169 patents (29%) were the dominating patent applications,
followed by 102 patent claims associated with antibodies (17%), 71 patents of industrial molecules (12%), 48 patents of
vaccines (8%), and finally 18 patents related to post-translational protein glycosylation (3%). The greatest proportion of
patentees was of US origin (52%), and PMF associated patenting activities at the USPTO and EPO were dominated with
67% by private organizations.
BASARAN Pervin;
RODRIGUEZ CEREZO Emilio;
2008-12-17
KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING
JRC44972
1226-8372,
http://www.springerlink.com/content/uxm7w81x434lx447/,
https://publications.jrc.ec.europa.eu/repository/handle/JRC44972,
10.1007/s12257-007-0092-y,
Additional supporting files
| File name | Description | File type | |
|---|
